High chance for cure
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:157 |
|---|---|
| Enthalten in: |
MMW Fortschritte der Medizin - 157(2015), 13 vom: 23. Juli, Seite 81 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Hohe Chance auf Heilung |
|---|
| Beteiligte Personen: |
Recker, Kathrina [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.12.2015 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/s15006-015-3371-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM251185044 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM251185044 | ||
| 003 | DE-627 | ||
| 005 | 20231224161443.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s15006-015-3371-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0837.xml |
| 035 | |a (DE-627)NLM251185044 | ||
| 035 | |a (NLM)26206055 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Recker, Kathrina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High chance for cure |
| 246 | 3 | 3 | |a Hohe Chance auf Heilung |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.12.2015 | ||
| 500 | |a Date Revised 03.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a News | |
| 650 | 7 | |a Anilides |2 NLM | |
| 650 | 7 | |a Carbamates |2 NLM | |
| 650 | 7 | |a Cyclopropanes |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 650 | 7 | |a Lactams, Macrocyclic |2 NLM | |
| 650 | 7 | |a Macrocyclic Compounds |2 NLM | |
| 650 | 7 | |a Sulfonamides |2 NLM | |
| 650 | 7 | |a ombitasvir |2 NLM | |
| 650 | 7 | |a 2302768XJ8 |2 NLM | |
| 650 | 7 | |a Uracil |2 NLM | |
| 650 | 7 | |a 56HH86ZVCT |2 NLM | |
| 650 | 7 | |a Proline |2 NLM | |
| 650 | 7 | |a 9DLQ4CIU6V |2 NLM | |
| 650 | 7 | |a 2-Naphthylamine |2 NLM | |
| 650 | 7 | |a CKR7XL41N4 |2 NLM | |
| 650 | 7 | |a dasabuvir |2 NLM | |
| 650 | 7 | |a DE54EQW8T1 |2 NLM | |
| 650 | 7 | |a Valine |2 NLM | |
| 650 | 7 | |a HG18B9YRS7 |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 650 | 7 | |a paritaprevir |2 NLM | |
| 650 | 7 | |a OU2YM37K86 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t MMW Fortschritte der Medizin |d 1999 |g 157(2015), 13 vom: 23. Juli, Seite 81 |w (DE-627)NLM103996869 |x 1613-3560 |7 nnns |
| 773 | 1 | 8 | |g volume:157 |g year:2015 |g number:13 |g day:23 |g month:07 |g pages:81 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s15006-015-3371-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 157 |j 2015 |e 13 |b 23 |c 07 |h 81 | ||